Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Bluebird Bio (BLUE)
Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 465,771
  • Shares Outstanding, K 109,336
  • Annual Sales, $ 3,600 K
  • Annual Income, $ -266,580 K
  • 60-Month Beta 0.98
  • Price/Sales 116.11
  • Price/Cash Flow N/A
  • Price/Book 1.84
Trade BLUE with:

Options Overview Details

View History
  • Implied Volatility 173.56% ( +3.49%)
  • Historical Volatility 96.34%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 173.56% on 12/01/23
  • IV Low 54.86% on 03/10/23
  • Put/Call Vol Ratio 0.44
  • Today's Volume 3,403
  • Volume Avg (30-Day) 2,972
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 109,859
  • Open Int (30-Day) 107,951

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.62
  • Number of Estimates 9
  • High Estimate 0.14
  • Low Estimate -1.02
  • Prior Year 0.38
  • Growth Rate Est. (year over year) -263.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.83 +50.53%
on 11/13/23
4.28 -0.47%
on 12/01/23
+1.32 (+44.90%)
since 11/01/23
3-Month
2.52 +69.05%
on 10/13/23
4.28 -0.47%
on 12/01/23
+0.36 (+9.23%)
since 09/01/23
52-Week
2.52 +69.05%
on 10/13/23
8.58 -50.35%
on 12/05/22
-3.35 (-44.02%)
since 12/01/22

Most Recent Stories

More News
2 Biotech Stocks That Could Soar in December

These two biotechs have important catalysts coming up in December.

BLUE : 4.26 (+11.52%)
GPCR : 59.57 (+6.97%)
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street

Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio?

MSFT : 374.51 (-1.16%)
GOOGL : 131.86 (-0.51%)
AAPL : 191.24 (+0.68%)
VRTX : 351.16 (-1.03%)
BLUE : 4.26 (+11.52%)
GOOG : 133.32 (-0.45%)
CRSP : 68.65 (+2.88%)
OPRA : 11.69 (+5.32%)
EDIT : 10.77 (+2.28%)
Why Bluebird Bio Stock Soared 7% Higher on Tuesday

The company posted some encouraging numbers and said it had sufficient resources to take care of financial obligations through the second quarter of 2024.

BLUE : 4.26 (+11.52%)
Bluebird: Q3 Earnings Snapshot

Bluebird: Q3 Earnings Snapshot

BLUE : 4.26 (+11.52%)
Is Bluebird Bio Stock a Buy?

This biotech looks cheap, but is it a value trap?

BLUE : 4.26 (+11.52%)
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient

This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.

REGN : 814.86 (-1.09%)
AMGN : 272.45 (+1.04%)
BLUE : 4.26 (+11.52%)
EDIT : 10.77 (+2.28%)
CRSP : 68.65 (+2.88%)
VRTX : 351.16 (-1.03%)
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?

The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome.

VRTX : 351.16 (-1.03%)
BLUE : 4.26 (+11.52%)
CRSP : 68.65 (+2.88%)
PFE : 28.91 (-5.12%)
ARKK : 48.43 (+5.03%)
ARKG : 29.03 (+4.65%)
BEAM : 29.57 (+5.31%)
Where Will Bluebird Bio Be in 1 Year?

Things could get better for the biotech, but they could also get worse.

BLUE : 4.26 (+11.52%)
Are Gene Therapy Stocks The Market's Next Big Winners?

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

SRPT : 84.44 (+3.89%)
BMRN : 92.42 (+1.47%)
BIIB : 234.64 (+0.24%)
CRSP : 68.65 (+2.88%)
EDIT : 10.77 (+2.28%)
NTLA : 30.84 (+4.08%)
NVS : 98.13 (+0.23%)
ORTX : 16.21 (unch)
REGN : 814.86 (-1.09%)
SLDB : 3.01 (+6.74%)
BLUE : 4.26 (+11.52%)
Better Growth Stock: CRISPR Therapeutics vs. Bluebird Bio

These two biotechs have a lot in common, but one is much better capitalized.

CRSP : 68.65 (+2.88%)
BLUE : 4.26 (+11.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic...

See More

Key Turning Points

3rd Resistance Point 4.96
2nd Resistance Point 4.62
1st Resistance Point 4.44
Last Price 4.26
1st Support Level 3.92
2nd Support Level 3.58
3rd Support Level 3.40

See More

52-Week High 8.58
Fibonacci 61.8% 6.27
Fibonacci 50% 5.55
Fibonacci 38.2% 4.83
Last Price 4.26
52-Week Low 2.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar